References
- Fanconi G. Familiare infantile perniziosaartige Anemia (perni-zioses Blutbild und Konstitution). Jahrbuch Kinder 1927; 117: 257.
- Glanz A, Fraser FC. Spectrum of anomalies in Fanconi anemia.J Med Genet 1982; 19: 412.
- Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991; 51: 1.
- Giampietro PF, Velander PC, Davis JG, Auerbach AD. Diagnosisof Fanconi anemia in patients with congenital malformation: an International Fanconi Anemia Registry. Am J Med Genet 1997; 68: 58–61.
- Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Oski FA. (eds) Hematology of infancy and childhood, 4th edn. Philadelphia, PA: WB Saunders, 1993; 216.
- Schroeder TM, Drings P, Beliner P, Buchinger G. Clinical and cytogenetic observations during a six year period in an adult with Fanconi's anemia. Blut 1976; 34: 119.
- Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973; 33: 1829.
- Auerbach AD, Schroeder TM. First announcement of the FanconiAnemia Registry. Blood 1982; 60: 1054.
- Babu Rao V, Kereketta L, Ghosh K, Mohanty D. A 46, XY, dup[1] (q 21 q32) add (11) (q23) karyotype in a case of Fanconi anemia. Leuk Res 2001; 25: 347–348.
- Athale UH, Rao SR, Kadam PR et al. Fanconi anemia: a clinohematological and cytogenetic study. Indian Pediatr 1992; 28: 1003.
- Talwar R, Choudhary VP, Kucheria K. Differentiation of Fanconianemia from 'idiopathic' aplastic anemia by induced chromosomal breakage using mitomycin-C (MMC). Indian Pediatr 2004; 41: 473–477.
- Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989; 73: 391.
- Dokal I. Fanconi's anemia and related bone marrow syndromes. Br Med Bull 2006; 77/78: 37–53.
- Rosenberg PS, Huang Y, Alter BP. Individualized risks of first adverse events in patients with Fanconi anemia. Blood 2004; 104: 350–355.
- Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006; 71: 107.
- Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993; 21: 731–736.
- Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822–826.
- Marrek O, Joveaux P, Le Coniat M et al. Fanconi anemia and bone marrow Clonal chromosomal abnormalities. Leukemia 1996; 10: 700.
- Tonnis HH, Kuhl JS, Gerlach A, Ebell W, Neitzel H. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gain of the chromosomal segment 3q,26q2q as an adverse risk factor. Blood 2003; 101: 3872–3874.
- Thurston VC, Ceperich TM, Vance GH, Heerema NA. Detection of monosomy 7 in bone marrow by fluorescence in situ hybridization. A study of Fanconi anemia patients and review of the literature. Cancer Genet Cytogenet 1999; 109(2): 154–160.